Q: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a ...

Patients with resected melanoma treated with a shorter duration of anti-PD1 therapy did not have worse outcomes than those treated for 12 months.

or they might move to a more aggressive treatment regimen that uses a combination of cancer drugs instead of just one, for ...

Teddi Mellencamp took to social media Wednesday to share a positive update on her cancer treatment — all of her brain and ...

DNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma.

In the early 90s, Kelly O'Donnell Ware was diagnosed with skin cancer. She got treatment for it and continued to live a ...

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Adjuvant treatment with dabrafenib and trametinib may be more effective than observation or adjuvant treatment with a PD-1 inhibitor in patients with stage IIIA melanoma.

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...